SynthesisProstate cancer and prostatic diseases2020

Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.

Yupeng Guan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.